Group One Trading’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-21,693
| Closed | -$106K | – | 7950 |
|
|
2025
Q1 | $106K | Buy |
+21,693
| New | +$130K | ﹤0.01% | 4555 |
|
|
2024
Q4 | – | Sell |
-9,431
| Closed | -$82.4K | – | 7282 |
|
|
2024
Q3 | $98K | Sell |
9,431
-6,652
| -41% | -$111K | ﹤0.01% | 4197 |
|
|
2024
Q2 | $317K | Sell |
16,083
-10,050
| -38% | -$201K | ﹤0.01% | 2986 |
|
|
2024
Q1 | $669K | Sell |
26,133
-21,272
| -45% | -$545K | ﹤0.01% | 2461 |
|
|
2023
Q4 | $1.31M | Buy |
47,405
+14,169
| +43% | +$864K | ﹤0.01% | 2216 |
|
|
2023
Q3 | $2.02M | Sell |
33,236
-6,562
| -16% | -$461K | 0.01% | 1635 |
|
|
2023
Q2 | $2.62M | Buy |
39,798
+31,752
| +395% | +$2.32M | 0.01% | 1458 |
|
|
2023
Q1 | $512K | Buy |
+8,046
| New | +$919K | ﹤0.01% | 2762 |
|
|
2022
Q4 | – | Sell |
-7,875
| Closed | -$1.11M | – | 7251 |
|
|
2022
Q3 | $997K | Buy |
7,875
+4,948
| +169% | +$560K | ﹤0.01% | 2591 |
|
|
2022
Q2 | $242K | Buy |
2,927
+1,211
| +71% | +$93.9K | ﹤0.01% | 4119 |
|
|
2022
Q1 | $166K | Sell |
1,716
-6,040
| -78% | -$797K | ﹤0.01% | 4992 |
|
|
2021
Q4 | $1.55M | Sell |
7,756
-5,080
| -40% | -$1.2M | ﹤0.01% | 2873 |
|
|
2021
Q3 | $3.18M | Buy |
12,836
+836
| +7% | +$239K | ﹤0.01% | 2178 |
|
|
2021
Q2 | $4.97M | Sell |
12,000
-2,417
| -17% | -$958K | 0.01% | 1694 |
|
|
2021
Q1 | $5.63M | Buy |
14,417
+8,198
| +132% | +$4.04M | 0.01% | 1414 |
|
|
2020
Q4 | $3.49M | Buy |
6,219
+4,561
| +275% | +$2.89M | 0.01% | 1579 |
|
|
2020
Q3 | $1.16M | Sell |
1,658
-629
| -28% | -$491K | ﹤0.01% | 2062 |
|
|
2020
Q2 | $1.81M | Sell |
2,287
-3,200
| -58% | -$2.41M | 0.01% | 1534 |
|
|
2020
Q1 | $3.27M | Buy |
5,487
+3,857
| +237% | +$3.76M | 0.03% | 745 |
|
|
2019
Q4 | $1.85M | Sell |
1,630
-111
| -6% | -$121K | 0.01% | 1337 |
|
|
2019
Q3 | $2.07M | Sell |
1,741
-831
| -32% | -$1.27M | 0.02% | 1194 |
|
|
2019
Q2 | $4.24M | Buy |
2,572
+2,179
| +554% | +$3.77M | 0.04% | 619 |
|
|
2019
Q1 | $800K | Sell |
393
-2,102
| -84% | -$3.7M | 0.01% | 1566 |
|
|
2018
Q4 | $3.21M | Sell |
2,495
-1,355
| -35% | -$2.08M | 0.03% | 736 |
|
|
2018
Q3 | $7.28M | Sell |
3,850
-391
| -9% | -$808K | 0.06% | 396 |
|
|
2018
Q2 | $8.62M | Buy |
4,241
+1,529
| +56% | +$3.49M | 0.07% | 302 |
|
|
2018
Q1 | $6M | Buy |
+2,712
| New | +$6.9M | 0.06% | 385 |
|
|
2017
Q2 | – | Sell |
-670
| Closed | -$808K | – | 4746 |
|
|
2017
Q1 | $789K | Buy |
670
+57
| +9% | +$58.1K | 0.01% | 1503 |
|
|
2016
Q4 | $490K | Sell |
613
-595
| -49% | -$472K | ﹤0.01% | 1787 |
|
|
2016
Q3 | $1.06M | Sell |
1,208
-853
| -41% | -$618K | 0.01% | 1242 |
|
|
2016
Q2 | $1.16M | Sell |
2,061
-1,964
| -49% | -$1.11M | 0.01% | 1167 |
|
|
2016
Q1 | $2.22M | Buy |
4,025
+918
| +30% | +$564K | 0.03% | 710 |
|
|
2015
Q4 | $2.58M | Buy |
3,107
+1,499
| +93% | +$1.5M | 0.03% | 704 |
|
|
2015
Q3 | $1.78M | Buy |
1,608
+1,535
| +2,103% | +$2.8M | 0.02% | 863 |
|
|
2015
Q2 | $159K | Sell |
73
-455
| -86% | -$927K | ﹤0.01% | 2714 |
|
|
2015
Q1 | $827K | Sell |
528
-498
| -49% | -$657K | 0.01% | 1230 |
|
|
2014
Q4 | $1.22M | Buy |
1,026
+908
| +769% | +$607K | 0.02% | 950 |
|
|
2014
Q3 | $55K | Buy |
+118
| New | +$54.4K | ﹤0.01% | 3450 |
|
|
2014
Q2 | – | Sell |
-173
| Closed | -$55.5K | – | 5167 |
|
|
2014
Q1 | $51K | Buy |
+173
| New | +$52.4K | ﹤0.01% | 3609 |
|
Other funds holding BLUE
Group One Trading's BLUE Position: Q2 2025 in Review
Group One Trading sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 21,693 shares — an estimated $106K sold.
Group One Trading first reported a position in BLUE in Q1 2014 and held it in 39 quarters. The position peaked at $8.62M in Q2 2018. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.
- Group One Trading reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
- Group One Trading sold 21,693 bluebird bio shares in Q2 2025, an estimated $106K.
- Group One Trading first reported a position in bluebird bio in Q1 2014 and held it in 39 quarters.
- Group One Trading's bluebird bio position peaked at $8.62M in Q2 2018.
- 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.
Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.